REFERENCES
- Jablonski J., Jablonska E., Chojnowski M. The influence of very low doses of N-nitrosodimethylamine (NDMA) on the apoptosis of rat neutrophils in vivo. The role of reactive oxygen species. Toxicology 2001; 165(1)65–74
- Jablonski J., Jablonska E., Moniuszko-Jakoniuk J., Holownia A. Evaluation of the influence of N-nitrosodimethyloamine (NDMA) on the apoptosis of neutrophils of peripheral blood (PMA) and the expression of the IL-6R membrane receptor — in vitro research. Immunol. Invest. 1999; 28(2–3)177–184
- Lee M-W., Park S.Ch., Yang Y.G., Yim S.O., Char H.S., et al. The involvment of reactive oxygen species (ROS) and p38-mitogen activated protein (MAP) kinase in TRAIL/Apo2L-induced apoptosis. FEBS Lett. 2002; 512(1–3)313–318
- Tecchio C., Huber V., Scapini P., Calzetti F., Margotto D., et al. IFNα-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) displaying apoptotic activity on leukemic cells. Blood 2004; 103(10)3837–3844
- Almasan A., Ashkenazi A. Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy. Cytokine Growth Factor Rev. 2003; 14(3–4)337–348
- Ehrlich S., Infante-Duarte C., Seeger B., Zipp F. Regulation of soluble and surface-bound TRAIL in human T cells, B cells, and monocytes. Cytokine 2003; 24(6)244–253
- Griffith T.S., Lynch D.H. TRAIL: a molecule with multiple receptors and control mechanisms. Curr. Opin. Immunol. 1998; 10(5)559–563
- Kamohara H., Matsuyama W., Shimozato O., Abe K., Galligan C., et al. Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptor expression in human neutrophils. Immunology 2004; 111(2)186–194
- Koga Y., Matsuzaki A., Suminoe A., Hattori H., Hara T. Neutrophil-derived TNF-related apoptosis-inducing ligand (TRAIL): a novel mechanism of antitumor effect by neutrophils. Cancer Res. 2004; 64(3)1037–1043
- MacFarlane M. TRAIL-induced signalling and apoptosis. Toxicol. Lett. 2003; 139(2–3)89–97
- Emery J.G., McDonnell P., Burke M.B., Deen K.C., Lyn S., et al. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J. Biol. Chem. 1998; 273(23)14363–14367
- Rossi D., Gaidano G. Messengers of cell death: apoptotic signaling in health and disease. Haematologica 2003; 88(2)212–218
- Renshaw S.A., Parmar J.S., Singleton V., Rowe S.J., Dockrell D.H., et al. Acceleration of human neutrophil apoptosis by TRAIL. J. Immunol. 2003; 170(2)1027–1033
- Cassatella M.A., Huber V., Calzetti F., Margotto D., Tamassia N., Peri G., Mantovani A., Rivoltini L., Tecchio C. Interferon-activated neutrophils store a TNF-related apoptosis-inducing lignad (TRAIL/Apo-2 ligand) intracellular pool that is readily mobolizable following exposure to proinflammatory mediators. J. Leukoc. Biol. 2006; 79(1)123–132
- Belinsky S.A., Devereux T.R., Anderson M.W. Role of DNA methylation in the activation of proto-oncogenes and the induction of pulmonary neoplasia by nitrosamines. Mutat. Res. 1990; 233(1–2)105–116